Primary healthcare for malaria elimination (PHC for ME)
Amref and GSK are partnering to strengthen Primary Health Care Systems for Malaria Elimination in Kenya and Zambia.
PHC for ME
Malaria is preventable, but it remains a global health burden.
COVID-19 accelerated the number of cases and deaths due to malaria across the world. In 2021, there were 247m cases and 619,000 deaths due to malaria. In 2019, pre-pandemic, there were 232m cases and 568,000 deaths due to malaria.
Africa continues to bear the highest malaria burden
These striking statistics show the urgent need to allocate resources to malaria prevention, treatment and elimination. Africa’s response to malaria is threatened by the scale of the burden, combined with rising biological threats related to climate change, anti-malarial resistance (AMR), and a new mosquito species – the Anopheles stephensi.
Programme aims
Amref is partnering with longstanding strategic partner GSK, to deliver the Primary healthcare for malaria elimination programme. It launched in November 2023 and will run until October 2026 in Kenya and Zambia.
The project sites include three Zambian provinces namely Northern, Luapula and Muchinga and two counties in Kenya (Busia and Siaya) all selected based on their high burden of malaria.
The project aims to strengthen primary healthcare systems for improved diagnosis, treatment, prevention, and surveillance of malaria cases in Kenya and Zambia. It prioritises vulnerable groups such as pregnant women, adolescent girls, people with disabilities, their children, and the elderly, aiming to address health inequities by bringing care closer to rural communities.
Programme activities
- Increase community awareness on prevention, access to services and vaccines
- Strengthen malaria commodity and technology supply chain management systems
- Strengthen social accountability for improved prevention, diagnosis and treatment of malaria
- Advocate for increased budget allocations for the health workforce and malaria
- Strengthen data use for decision-making
- Strengthen multisector engagement at national and sub national levels
- Strengthen malaria programming including intersectionality with climate change
Key achievements
In October 2024, both projects in Kenya and Zambia had started implementation and early achievements include:
With thanks to GSK for its support of the programme, and its continued commitment to tackling the malaria burden in Africa. The Amref-GSK partnership started more than 35 years ago with an impregnated mosquito net distribution project in Kenya. We are pleased to continue our work together using the latest tools and techniques to get ahead of disease and create lasting health change.
